The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Docon Technologies Private Limited, the promoter of Thyrocare with a 71.06% stake (3,76,56,092 equity shares), has released the pledge on its entire shareholding in Thyrocare. The shares were previously pledged with Vistra ITCL (India) Limited as Debenture Trustee to secure non-convertible debentures worth INR 1,545.38 crore issued by API Holdings (the ultimate parent company). API Holdings is now raising fresh debentures of up to INR 1,700 crore to fully redeem the earlier debt, which triggered the release of the pledge effective September 16, 2025. No change in the promoter's underlying shareholding — only the encumbrance has been removed.
Removes a significant overhang on Thyrocare stock as the entire promoter holding was pledged, which had posed a risk of forced selling. The simultaneous debt restructuring at the parent level is seen as a positive signal, reducing financial stress concerns for retail shareholders.